Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Skaug

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Scandinavian Journal of Infectious Diseases|January 1, 1996
Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxisO Dunlop, V Rootwelt, M Sannes, et al.
Scandinavian Journal of Gastroenterology|March 28, 2002
Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre studyK Bjøro, H Bell, B Myrvang, et al.
Scandinavian Journal of Gastroenterology|March 28, 1998
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT GroupL M Jarvis, H Bell, P Simmonds, et al.
Scandinavian Journal of Gastroenterology|April 7, 1999
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT GroupH Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct groupH Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Gastroenterology|January 23, 1998
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot studyI Nordøy, H B Krarup, H Bell, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Scandinavian Journal of Infectious Diseases|January 1, 1996
Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxisO Dunlop, V Rootwelt, M Sannes, et al.
Scandinavian Journal of Gastroenterology|March 28, 2002
Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre studyK Bjøro, H Bell, B Myrvang, et al.
Scandinavian Journal of Gastroenterology|March 28, 1998
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT GroupL M Jarvis, H Bell, P Simmonds, et al.
Scandinavian Journal of Gastroenterology|April 7, 1999
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT GroupH Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct groupH Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Gastroenterology|January 23, 1998
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot studyI Nordøy, H B Krarup, H Bell, et al.
Pageof 8